LON:KMK Kromek Group Share Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Kromek Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 11.88 0.00 (0.00 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range 11.75Now: GBX 11.88▼ 1250-Day Range 11.88MA: GBX 14.08▼ 16.3852-Week Range 8.70Now: GBX 11.88▼ 28Volume379,981 shsAverage Volume764,577 shsMarket Capitalization£40.92 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsEarningsInsider TradesHeadlines Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection products for applications in the medical, nuclear, and security screening markets worldwide. Its solutions provide high resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials, as well as for the analysis of radioactive materials. The company also provides a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology, such as handheld rugged gamma detectors, thermal neutron detectors, gamma-ray detector spectrometers, scintillator detectors, preamplifiers for radiation detectors and detector electronics, and gamma-ray CZT detectors. In addition, it offers medical imaging products, including CZT gamma cameras for SPECT imaging, CZT surgical gamma probes, CZT bone mineral densitometry, and photon-counting spectral CT. Further, the company provides security products, such as D3S wearable RIID gamma neutron detectors; liquid explosive detection algorithm for type c systems; Identifier liquid explosive detectors; and X-ray scalable linear arrays. Additionally, it engages in scientific research and development activities. Kromek Group plc was incorporated in 2003 and is headquartered in Sedgefield, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Kromek Group. Previous Next 2.7 Community Rank Outperform VotesKromek Group has received 206 “outperform” votes. (Add your “outperform” vote.)Underperform VotesKromek Group has received 176 “underperform” votes. (Add your “underperform” vote.)Community SentimentKromek Group has received 53.93% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Kromek Group and other stocks. Vote “Outperform” if you believe KMK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe KMK will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldKromek Group does not currently pay a dividend.Dividend GrowthKromek Group does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Kromek Group insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Kromek Group is -29.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Kromek Group is -29.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKromek Group has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.67 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolLON:KMK Previous Symbol CUSIPN/A CIKN/A Webwww.kromek.com Phone+44-1740-626060Debt Debt-to-Equity Ratio16.69 Current Ratio4.20 Quick Ratio3.76Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£16.17 million Price / Sales2.53 Cash FlowGBX 3.86 per share Price / Cash Flow3.08 Book ValueGBX 17.10 per share Price / Book0.69Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees100 Outstanding Shares344,559,008Market Cap£40.92 million Next Earnings DateN/A OptionableNot Optionable GBX 11.88 0.00 (0.00 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive KMK News and Ratings via Email Sign-up to receive the latest news and ratings for KMK and its competitors with MarketBeat's FREE daily newsletter. Kromek Group (LON:KMK) Frequently Asked Questions How has Kromek Group's stock been impacted by COVID-19? Kromek Group's stock was trading at GBX 18 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, KMK shares have decreased by 34.0% and is now trading at GBX 11.88. View which stocks have been most impacted by COVID-19. How were Kromek Group's earnings last quarter? Kromek Group PLC (LON:KMK) posted its quarterly earnings data on Wednesday, December, 11th. The company reported ($0.70) earnings per share for the quarter. View Kromek Group's earnings history. Who are some of Kromek Group's key competitors? Some companies that are related to Kromek Group include Medica Group (MGP), Advanced Oncotherapy (AVO), Patient Home Monitoring (PTQ), MRI Interventions (CLPT), Electromed (ELMD), Electromed (ELMD), Titan Medical (TMD), MRI Interventions (MRIC), Protech Home Medical (PHM), Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), Delcath Systems (DCTH), Helius Medical Technologies (HSM), Myomo (MYO) and Myomo (MYO). View all competitors. What other stocks do shareholders of Kromek Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Kromek Group investors own include Eden Research (EDEN), Alkane Energy (ALK), Surgical Innovations Group (SUN), Carclo (CAR), Baozun (BZUN), Bahamas Petroleum (BPC), Bonmarche (BON), Bristol-Myers Squibb (BMY), BK CHINA LTD/ADR (BACHY) and Alibaba Group (BABA). Who are Kromek Group's key executives? Kromek Group's management team includes the following people: Dr. Arnab Basu, CEO & Exec. Director (Age 46)Mr. Derek Bulmer, CFO, Company Sec. & Exec. Director (Age 53)Mr. Berry Beumer, Chief Operating OfficerMr. Ian Radley, Chief Technical Officer (Age 62)Prof. Brian Keith Tanner MA, DPhil, CPhys, FInstP, FRSA, Advisor (Age 71) What is Kromek Group's stock symbol? Kromek Group trades on the London Stock Exchange (LON) under the ticker symbol "KMK." How do I buy shares of Kromek Group? Shares of KMK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Kromek Group's stock price today? One share of KMK stock can currently be purchased for approximately GBX 11.88. How big of a company is Kromek Group? Kromek Group has a market capitalization of £40.92 million and generates £16.17 million in revenue each year. Kromek Group employs 100 workers across the globe. What is Kromek Group's official website? The official website for Kromek Group is www.kromek.com. How can I contact Kromek Group? Kromek Group's mailing address is Netpark Incubator, Thomas Wright Way, STOCKTON-ON-TEES, TS21 3FD, United Kingdom. The company can be reached via phone at +44-1740-626060. This page was last updated on 9/19/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
